Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 2716 AL 2730

Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial

Busse M, Quinn L, Dawes H, Jones C, Kelson M, Poile V, Trubey R, Townson J, Edwards RT, Rosser A, Hood K.

Trials. 2014 Dec 12;15:487. doi: 10.1186/1745-6215-15-487.

Focal EEG slowing and chorea: electroclinical clues to the diagnosis of anti-NMDAR encephalitis

Osei-Lah A, Durrant E, Hussain M, Kirkham F.

Epileptic Disord. 2014 Dec;16(4):482-5. doi: 10.1684/epd.2014.0708.

Hypercalcaemia mimicking Huntington's disease: lessons learned from delayed diagnosis

Hrastelj J, McLauchlan D, Rosser A, Clenaghan C.

J R Coll Physicians Edinb. 2014;44(4):286-8. doi: 10.4997/JRCPE.2014.407.

Dual effect of oxidative stress on leukemia cancer induction and treatment

Udensi UK, Tchounwou PB.

J Exp Clin Cancer Res. 2014 Dec 18;33:106. doi: 10.1186/s13046-014-0106-5.

Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient

Reddington AE, Rosser AE, Dunnett SB.

Front Cell Neurosci. 2014 Dec 2;8:398. doi: 10.3389/fncel.2014.00398. eCollection 2014.

Regulation of dopamine signaling in the striatum by phosphodiesterase inhibitors: novel therapeutics to treat neurological and psychiatric disorders

Ramirez AD, Smith SM.

Cent Nerv Syst Agents Med Chem. 2014;14(2):72-82. doi: 10.2174/1871524914666141226103421.

Aggression in Huntington's disease: a systematic review of rates of aggression and treatment methods

Fisher CA, Sewell K, Brown A, Churchyard A.

J Huntingtons Dis. 2014;3(4):319-32. doi: 10.3233/JHD-140127.

Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease

Miller S, Hill Della Puppa G, Reidling J, Marcora E, Thompson LM, Treanor J.

J Huntingtons Dis. 2014;3(4):333-41. doi: 10.3233/JHD-140129.

[Movement disorders is psychiatric diseases]

Hidasi Z, Salacz P, Csibri E.

Neuropsychopharmacol Hung. 2014 Dec;16(4):205-11.

A review of creatine supplementation in age-related diseases: more than a supplement for athletes

Smith RN, Agharkar AS, Gonzales EB.

F1000Res. 2014 Sep 15;3:222. doi: 10.12688/f1000research.5218.1. eCollection 2014.

[Huntington's disease: cellular and molecular basis of pathology]

Korzhova VV, Artamonov DN, Vlasova OL, Bezprozvannyĭ IB.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2014 Jul-Aug;64(4):359-75.

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder

Leuchter AF, Hunter AM, Krantz DE, Cook IA.

Dialogues Clin Neurosci. 2014 Dec;16(4):525-37. doi: 10.31887/DCNS.2014.16.4/aleuchter.

Mechanisms of amyloid fibril formation

Dovidchenko NV, Leonova EI, Galzitskaya OV.

Biochemistry (Mosc). 2014 Dec;79(13):1515-27. doi: 10.1134/S0006297914130057.

[Case report: A case of diabetic chorea associated hyperviscosity without abnormal findings of magnetic resonance imaging]

Shimizu M, Ohe M, Ono A, Nam Y, Takei S, Tsuda H, Irie T, Hibino M, Kamei T.

Nihon Naika Gakkai Zasshi. 2014 Dec 10;103(12):3103-5. doi: 10.2169/naika.103.3103.

FUS colocalizes with polyglutamine, but not with TDP-43 in neuronal intranuclear inclusions in spinocerebellar ataxia type 2

Mori F, Toyoshima Y, Tanji K, Kakita A, Takahashi H, Wakabayashi K.

Neuropathol Appl Neurobiol. 2014 Apr;40(3):351-5. doi: 10.1111/nan.12075.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias